NewEdge Wealth LLC Makes New Investment in Globe Life Inc. $GL

NewEdge Wealth LLC bought a new stake in Globe Life Inc. (NYSE:GL) during the 3rd quarter, HoldingsChannel.com reports. The firm bought 4,004 shares of the company’s stock, valued at approximately $536,000.

Other institutional investors have also recently made changes to their positions in the company. Mather Group LLC. purchased a new stake in shares of Globe Life during the third quarter worth approximately $28,000. CYBER HORNET ETFs LLC purchased a new position in Globe Life in the 2nd quarter valued at $28,000. Assetmark Inc. boosted its stake in Globe Life by 777.8% during the 2nd quarter. Assetmark Inc. now owns 237 shares of the company’s stock worth $29,000 after purchasing an additional 210 shares during the last quarter. MUFG Securities EMEA plc acquired a new stake in Globe Life during the 2nd quarter worth $31,000. Finally, Quent Capital LLC purchased a new stake in shares of Globe Life during the third quarter worth $36,000. 81.61% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Globe Life news, EVP Michael Clay Majors sold 30,000 shares of the company’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $146.89, for a total value of $4,406,700.00. Following the transaction, the executive vice president owned 47,066 shares of the company’s stock, valued at $6,913,524.74. This represents a 38.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Mark A. Blinn sold 1,750 shares of the stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $147.91, for a total transaction of $258,842.50. Following the transaction, the director directly owned 3,372 shares of the company’s stock, valued at approximately $498,752.52. This trade represents a 34.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 63,629 shares of company stock worth $9,223,785. Company insiders own 1.97% of the company’s stock.

Globe Life Stock Performance

Globe Life stock opened at $142.72 on Tuesday. The firm has a 50 day simple moving average of $141.48 and a 200-day simple moving average of $138.59. The stock has a market cap of $11.36 billion, a price-to-earnings ratio of 10.14 and a beta of 0.47. The company has a debt-to-equity ratio of 0.41, a current ratio of 0.07 and a quick ratio of 0.07. Globe Life Inc. has a 1-year low of $109.38 and a 1-year high of $152.71.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, February 4th. The company reported $3.39 EPS for the quarter, missing the consensus estimate of $3.44 by ($0.05). The firm had revenue of $1.52 billion for the quarter, compared to analysts’ expectations of $1.53 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The firm’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, analysts expect that Globe Life Inc. will post 13.87 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on GL. Keefe, Bruyette & Woods raised their price target on shares of Globe Life from $160.00 to $162.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 28th. Piper Sandler reiterated an “overweight” rating and issued a $167.00 price objective on shares of Globe Life in a report on Friday, November 21st. TD Cowen reissued a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. JPMorgan Chase & Co. upped their price target on Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Finally, Weiss Ratings raised Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, February 13th. Eight research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $171.22.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.